MedTrace Logo

The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy

NCT03838432 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2019-12-17

No results posted yet for this study

Summary

This trial is studying the effects and safety in treating patients from five different centers with local prostate cancer, employing Composite Steep-pulse(High-frequency irreversible electroporation) Treatment Apparatus. This device could cause cell irreversible electroporation, which leading necrosis of tumor cells. It also has the ability to prevent nerve,vessel, urethral and capsule unnecessary injury beside the ablation area. Composite Steep-pulse Treatment Apparatus will be used in patients who pass inclusion/exclusion criteria. Safety, quality of life, and histopathological analysis of prostate speciem will be evaluated in each study patients.

Conditions

Interventions

DEVICE

Steep Pulse Device

Applying the steep pulse to treat the patients with Prostate cancer

Sponsors & Collaborators

  • RenJi Hospital

    collaborator OTHER

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Zhejiang University

    collaborator OTHER

  • Second Military Medical University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-02
Primary Completion
2019-09-27
Completion
2020-01-18

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03838432 on ClinicalTrials.gov